| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -38% |
| 3Y CAGR | +22% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +48% |
| 3Y CAGR | +49% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,890.80 -87.40 (1.76%) | 22,759.95 | 30.96 | 5.42 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,501.20 -59.60 (2.33%) | 19,444.55 | 28.68 | 5.42 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,231.50 -184.00 (2.48%) | 18,526.25 | 109.22 | 21.23 | ||
Natco PharmaNATCOPHARM | ₹885.10 +2.70 (0.31%) | 15,806.45 | 13.81 | 1.71 |